Interrupting the adenoma-carcinoma sequence: screening for adenomas and cancer, now and in the future.
Semin Gastrointest Dis
; 11(4): 219-28, 2000 Oct.
Article
en En
| MEDLINE
| ID: mdl-11057949
ABSTRACT
Screening for colorectal cancer is only beginning to receive the attention it deserves. As screening emerges into the mainstream and utilization increases, competing technologies will battle to assume a greater percentage of the market share of testing. In this review, the standards and principles with which screening tests are evaluated are outlined. Current modalities for screening, including fecal occult blood testing (FOBT), flexible sigmoidoscopy, colonoscopy, barium enema, and the combination of FOBT with sigmoidoscopy, are discussed and critically reviewed. New techniques and technologies for screening, including virtual colonoscopy and molecular methods of screening stool, are previewed. Increased attention on screening and the competition for supremacy among the modalities undergoing evaluation make the prospects for a continued diminution in colorectal cancer mortality promising.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Carcinoma
/
Neoplasias Colorrectales
/
Adenoma
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Semin Gastrointest Dis
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2000
Tipo del documento:
Article
País de afiliación:
Estados Unidos